CD BioSciences supports integrated solutions for First-in-human (FIH) studies with flexibility.
We offer stringent participant oversight to ensure safety conduction of various ascending dose studies to advance the critical milestone in early clinical development.
Our mission is to provide our clients with innovative perspectives on the design and analysis of their clinical trials or studies. And by developing high quality databases, delivering comprehensive statistical reports and final statistical files used for regulatory submission, we’ll help our clients to achieve effective and successful research goals.
A full range of clinical trial consulting, design, conduction, management, reporting and analysis services for scientists and researchers all over the world.
